Sign In
Buy COR
$263.64
-1.20 (-0.453%)
At Close: Jun 03, 2026
Cencora (COR) Is Up 2.40% in One Week: What You Should Know
01:01pm, Wednesday, 28'th Feb 2024
Does Cencora (COR) have what it takes to be a top stock pick for momentum investors? Let's find out.
Cencora says hit by cyber attack on its information systems
05:56pm, Tuesday, 27'th Feb 2024
Cencora Inc said it has learned that data from its information systems had been exfiltrated, some of which may contain personal information, the drug distributor said in a filing on Tuesday.
Cencora, Inc. (COR) Hit a 52 Week High, Can the Run Continue?
10:16am, Tuesday, 27'th Feb 2024
Cencora (COR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Cencora Stock Building Bullish Chart Pattern After Earnings Jump
03:01pm, Thursday, 22'nd Feb 2024
Cencora stock reached new highs after its earnings report late January. The drug stock is trading tightly and may be poised for a move.
3 Medical Services Stocks to Buy Amid Industry Headwinds
11:36am, Friday, 09'th Feb 2024
The Zacks Medical - Services industry is growing on digital healthcare adoption. ELV, COR and HQY are set to gain the most.
Is Cencora, Inc. (COR) Stock Outpacing Its Medical Peers This Year?
10:47am, Wednesday, 07'th Feb 2024
Here is how Cencora (COR) and Cigna (CI) have performed compared to their sector so far this year.
Cencora (COR) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
10:37am, Thursday, 01'st Feb 2024
The headline numbers for Cencora (COR) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estima
Cencora (COR) Beats on Q1 Earnings & Revenues, Ups 2024 Outlook
11:16am, Wednesday, 31'st Jan 2024
Cencora's (COR) first-quarter fiscal 2024 results benefit from overall market growth, including rising demand for GLP-1 drugs and COVID-19 vaccines. Inflationary pressure remains.
Cencora (COR) Q1 Earnings and Revenues Surpass Estimates
08:41am, Wednesday, 31'st Jan 2024
Cencora (COR) came out with quarterly earnings of $3.28 per share, beating the Zacks Consensus Estimate of $2.86 per share. This compares to earnings of $2.71 per share a year ago.
Cencora raises profit outlook due to robust demand for high-priced specialty drug
08:19am, Wednesday, 31'st Jan 2024
Drug distributor Cencora raised its annual profit outlook on Wednesday, betting on strong demand for costly specialty medicines that treat diseases such as cancer and rheumatoid arthritis.
Why Cencora (COR) Could Beat Earnings Estimates Again
01:11pm, Tuesday, 30'th Jan 2024
Cencora (COR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Unlocking Q1 Potential of Cencora (COR): Exploring Wall Street Estimates for Key Metrics
10:21am, Friday, 26'th Jan 2024
Besides Wall Street's top -and-bottom-line estimates for Cencora (COR), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the qua
Cencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run?
10:16am, Monday, 22'nd Jan 2024
Cencora (COR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Cencora Announces Date and Time for First Quarter Fiscal 2024 Earnings Release
04:30pm, Thursday, 04'th Jan 2024
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the First Quarter of Fiscal 2024 on Wednesday, January 31, 2024, prior to the ope
5 Broker-Favored Stocks to Keep an Eye on in the Current Year
07:31am, Thursday, 04'th Jan 2024
We believe that stocks like American Airlines (AAL), Alaska Air Group (ALK), Cencora (COR), Cleveland-Cliffs (CLF) and Avnet (AVT) should be on an investor's watchlist.
